Altimmune Inc (ALT)
6.62
+0.02
(+0.30%)
USD |
NASDAQ |
Jul 05, 16:00
6.61
-0.01
(-0.15%)
After-Hours: 20:00
Altimmune Long Term Notes Receivable (Quarterly)
Long Term Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Long Term Notes Receivable (Quarterly) Data
Date | Value |
---|
Non-current Note Receivables Definition
Non-current Note Receivables are the written obligations the creditors receive from the debtors in exchange for funds that are not due within the next twelve months. It is part of a company’s long term assets.
Long Term Notes Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Long Term Notes Receivable (Quarterly) Benchmarks
Eli Lilly and Co | -- |
Amgen Inc | -- |
Pfizer Inc | -- |
Viking Therapeutics Inc | -- |
Inari Medical Inc | -- |